Downgrades Buy Hold X

AMRS Amyris

Jefferies

$3.10 $0.65

Downgrades Outperform Mkt Perform X

AMRS Amyris

TD Cowen

$4 $1.25

Initiated Buy X

AMRS Amyris

Canaccord Genuity

$1.50

Downgrades Overweight Neutral X

AMRS Amyris

JP Morgan

Downgrades Outperform Perform X

AMRS Amyris

Oppenheimer

Downgrades Buy Neutral X

AMRS Amyris

ROTH Capital

$4 $2

Initiated Neutral X

AMRS Amyris

JP Morgan

Initiated Neutral X

AMRS Amyris

Piper Sandler

$2.50

Resumed Outperform X

AMRS Amyris

Cowen

$19

Initiated Buy X

AMRS Amyris

HSBC Securities

$20

Reiterated Buy X

AMRS Amyris

H.C. Wainwright

$11 $35

Initiated Buy X

AMRS Amyris

ROTH Capital

$20

Upgrades Mkt Perform Outperform X

AMRS Amyris

Cowen

$9

Reiterated Buy X

AMRS Amyris

B. Riley FBR

$10 $8

AMRS  Amyris, Inc.

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.